Literature DB >> 11044969

Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation.

B L Kasiske1, M A Vazquez, W E Harmon, R S Brown, G M Danovitch, R S Gaston, D Roth, J D Scandling, G G Singer.   

Abstract

Many complications after renal transplantation can be prevented if they are detected early. Guidelines have been developed for the prevention of diseases in the general population, but there are no comprehensive guidelines for the prevention of diseases and complications after renal transplantation. Therefore, the Clinical Practice Guidelines Committee of the American Society of Transplantation developed these guidelines to help physicians and other health care workers provide optimal care for renal transplant recipients. The guidelines are also intended to indirectly help patients receive the access to care that they need to ensure long-term allograft survival, by attempting to systematically define what that care encompasses. The guidelines are applicable to all adult and pediatric renal transplant recipients, and they cover the outpatient screening for and prevention of diseases and complications that commonly occur after renal transplantation. They do not cover the diagnosis and treatment of diseases and complications after they become manifest, and they do not cover the pretransplant evaluation of renal transplant candidates. The guidelines are comprehensive, but they do not pretend to cover every aspect of care. As much as possible, the guidelines are evidence-based, and each recommendation has been given a subjective grade to indicate the strength of evidence that supports the recommendation. It is hoped that these guidelines will provide a framework for additional discussion and research that will improve the care of renal transplant recipients.

Entities:  

Mesh:

Year:  2000        PMID: 11044969

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  86 in total

1.  Skin cancer surveillance in renal transplant recipients: questionnaire survey of current UK practice.

Authors:  P N Harden; S M Reece; A A Fryer; A G Smith; H M Ramsay
Journal:  BMJ       Date:  2001-09-15

2.  The care of patients with chronic kidney disease.

Authors:  Annamaria T Kausz; Andrew S Levey
Journal:  J Gen Intern Med       Date:  2002-08       Impact factor: 5.128

3.  Prostate Cancer Screening and Management in Solid Organ Transplant Candidates and Recipients.

Authors:  Ezequiel Becher; Alex Wang; Herbert Lepor
Journal:  Rev Urol       Date:  2019

4.  HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients.

Authors:  Wijtske Annema; Arne Dikkers; Jan Freark de Boer; Robin P F Dullaart; Jan-Stephan F Sanders; Stephan J L Bakker; Uwe J F Tietge
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

Review 5.  A meta-analysis on diagnostic value of serum cystatin C and creatinine for the evaluation of glomerular filtration function in renal transplant patients.

Authors:  Pan Pan; Hu Binjie; Li Min; Fan Lipei; Ni Yanli; Zhou Junwen; Shi Xianghua
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

6.  Current management of corticosteroid-induced osteoporosis: variations in awareness and management.

Authors:  J G Ryan; R K Morgan; P J Lavin; F E Murray; P G O'Connell
Journal:  Ir J Med Sci       Date:  2004 Jan-Mar       Impact factor: 1.568

7.  Incidence and clinicopathologic behavior of uterine cervical carcinoma in renal transplant recipients.

Authors:  Sung Taek Park; Min Jong Song; Jong Sup Park; Soo Young Hur; Chung Won Lee
Journal:  World J Surg Oncol       Date:  2011-07-13       Impact factor: 2.754

Review 8.  Cancer screening in renal transplant recipients: what is the evidence?

Authors:  Germaine Wong; Jeremy R Chapman; Jonathan C Craig
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

9.  A rare case of minimal deviation adenocarcinoma of the uterine cervix in a renal transplant recipient.

Authors:  D M Fanning; C Gulmann; D P Hickey; D M Little
Journal:  Ir J Med Sci       Date:  2009-02-03       Impact factor: 1.568

10.  Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantation.

Authors:  Stephanie R Earnshaw; Christopher N Graham; William D Irish; Reiko Sato; Mark A Schnitzler
Journal:  J Am Soc Nephrol       Date:  2008-06-18       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.